MICHAEL D. BLASZYK - 09 Jun 2022 Form 4 Insider Report for NantHealth, Inc. (NHIQ)

Role
Director
Signature
/s/ Brandon Villery, as Attorney-in-Fact
Issuer symbol
NHIQ
Transactions as of
09 Jun 2022
Net transactions value
$0
Form type
4
Filing time
10 Jun 2022, 16:29:26 UTC
Previous filing
26 Jul 2021
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHIQ Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 09 Jun 2022 Common Stock 100,000 $0.5823 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date.